| ARVIND REMEDIES LIMITED | ||||||||||||||
| UNAUDITED FINANCIAL RESULTS | ||||||||||||||
| FOR THE THREE MONTHS AND HALF YEAR ENDED SEPTEMBER 30, 2007 | ||||||||||||||
| (Rupees in Lakhs.) | ||||||||||||||
| Particulars | Three months ended 30.09.2007 | Three months ended 30.09.2006 | Corresponding six months ended 30.09.2007 | Corresponding six months ended 30.09.2006 | Year ended 31.3.2007 | |||||||||
| Unaudited | Unaudited | Unaudited | Unaudited | Audited | ||||||||||
| Gross Sales | 4963.45 | 4196.73 | 9,559.25 | 8,588.68 | 17,972.93 | |||||||||
| Less: Excise Duty | (622.88) | (618.19) | (1,171.46) | (1,092.27) | (2,314.43) | |||||||||
| Net Sales | 4,340.57 | 3,578.54 | 8,387.79 | 7,496.41 | 15,658.50 | |||||||||
| Other Income | 6.33 | 8.69 | 8.91 | 11.47 | 21.58 | |||||||||
| Total Income | 4,346.90 | 3,587.23 | 8,396.70 | 7,507.88 | 15,680.08 | |||||||||
| Expenditure : | ||||||||||||||
| a) (Increase) / Decrease in Stock | 168.86 | (52.51) | (86.76) | 100.88 | (300.68) | |||||||||
| b) Consumption of raw materials | 3646.06 | 3,173.70 | 7,203.17 | 6,264.53 | 13,563.16 | |||||||||
| c) Purchase of traded goods | - | - | 30.80 | 30.90 | 84.47 | |||||||||
| d) Employee Cost | 101.58 | 81.48 | 194.10 | 159.74 | 340.42 | |||||||||
| e) Depreciation | 44.35 | 41.74 | 87.99 | 82.95 | 170.12 | |||||||||
| f) Other expenditure | 118.87 | 119.33 | 249.41 | 231.89 | 618.13 | |||||||||
| Total (a) to (f) | 4,079.72 | 3,363.74 | 7,678.71 | 6,870.89 | 14,475.62 | |||||||||
| Interest | 164.75 | 133.28 | 328.12 | 267.53 | 655.18 | |||||||||
| Exceptional Items | - | - | - | - | - | |||||||||
| Profit from ordinary activities before tax | 102.43 | 90.21 | 389.87 | 369.46 | 549.28 | |||||||||
| Provision for Taxation | ||||||||||||||
| Income Tax (Including Fringe Benefit Tax) | 13.27 | 20.00 | 40.00 | 40.00 | 85.86 | |||||||||
| Earlier years | - | 0.12 | - | 0.12 | (31.48) | |||||||||
| Deferred Tax | (10.76) | (11.08) | (23.48) | (21.11) | 56.13 | |||||||||
| Wealth Tax | - | - | 0.29 | |||||||||||
| Profit from ordinary activities after tax | 99.92 | 81.17 | 373.35 | 350.45 | 438.48 | |||||||||
| Extraordinary Items (net of tax expense) | - | - | - | - | - | |||||||||
| Net profit for the period | 99.92 | 81.17 | 373.35 | 350.45 | 438.48 | |||||||||
| Paid-up Equity Share Capital | 2600.50 | 2600.50 | 2600.50 | 2600.50 | 2600.50 | |||||||||
| (face value Re. 1/- per Share) | ||||||||||||||
| Reserves excluding Revaluation Reserve | - | - | - | - | 1,521.31 | |||||||||
| Basic and Diluted Earnings Per Share before and after extraordinary items (Rs.) | 0.04 | 0.03 | 0.14 | 0.13 | 0.17 | |||||||||
| Public Shareholding | ||||||||||||||
| Number of shares | 194205340 | 194205340 | 194205340 | 194205340 | 194205340 | |||||||||
| Percentage of Shareholding | 74.68% | 74.68% | 74.68% | 74.68% | 74.68% | |||||||||
| Notes : | ||||||||||||||
| 1. The Company operates only in one business segment namely formulations. | ||||||||||||||
| 2. Previous period's figures have been regrouped / rearranged wherever necessary to confirm to the current periods classification. | ||||||||||||||
| 3. The revised Accounting Standard 15 "Employee Benefits" issued by the Institute of Chartered Accountants of India has become applicable to the Company with effect | ||||||||||||||
| from April 1, 2007. The impact of such revision, which is not likely to be material, will be considered at the year end. | ||||||||||||||
| 4. Provision for taxation for the six months ended September 30, 2007 has been made on an estimate basis. The actual tax liability will be determined on the basis of | ||||||||||||||
| the taxable income of the Company for the year from April 1, 2007 to March 31, 2008. | ||||||||||||||
| 5. The above results were reviewed by the audit committee and taken on record at the meeting of the Board of Directors held on November 30, 2007. | ||||||||||||||
| 6. During the quarter nil investor complaints were received and disposed off. There were no investor complaints pending for the redressal as at the | ||||||||||||||
| the commencement and end of the quarter. | ||||||||||||||
| 7. The above results have been subjected to a Limited Review by the statutory auditors as per the listing agreement with the stock exchanges. | ||||||||||||||
| Chennai - 600 084 | For ARVIND REMEDIES LTD. | |||||||||||||
| Date: November 30, 2007 | ||||||||||||||
| Dr. Chandra Ravindran | ||||||||||||||
| Director | ||||||||||||||